Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 8.12B 2.16B 1.95B 1.8B 1.63B 3.08B 203B 3.16B 21.59B 8.61B 109B 7.95B 346B P/E 2026 *
16.6x
P/E 2027 * 15x
Enterprise Value 7.79B 2.08B 1.87B 1.73B 1.56B 2.96B 195B 3.03B 20.72B 8.26B 104B 7.63B 332B EV / Sales 2026 *
4.73x
EV / Sales 2027 * 4.24x
Free-Float
38.61%
Yield 2026 *
3.43%
Yield 2027 * 3.78%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-0.26%
1 week+1.31%
Current month-3.50%
1 month-6.16%
3 months-18.29%
6 months-26.07%
Current year-18.69%
1 week 112.8
Extreme 112.8
117
1 month 112.2
Extreme 112.2
126.6
Current year 112.2
Extreme 112.2
163.7
1 year 112.2
Extreme 112.2
163.7
3 years 103
Extreme 103
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2021
Director of Finance/CFO 62 13/01/2013
Chief Operating Officer 31 01/09/2021
Director TitleAgeSince
Chairman 66 19/06/2022
Director/Board Member 41 19/06/2022
Director/Board Member 65 19/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+1.31%-22.35%+11.90% 2.16B
+0.35%+1.36%+45.38%+140.47% 1,280B
-0.13%+1.48%+44.67%+90.43% 675B
+0.37%+0.05%+31.00%+112.84% 521B
+0.93%+1.52%+39.21%+69.76% 386B
-0.59%-2.11%+61.83%+45.16% 363B
+1.66%-1.13%+27.54%+58.29% 301B
+1.17%-0.91%+3.19%+37.72% 286B
+0.62%-2.17%+38.31%+75.12% 253B
-0.67%-2.72%+38.49%+123.56% 211B
Average +0.52%-0.36%+30.73%+76.52% 428B
Weighted average by Cap. +0.84%+0.20%+39.48%+97.33%

Financials

2026 *2027 *
Net sales 1.65B 439M 396M 366M 331M 626M 41.2B 641M 4.38B 1.75B 22.07B 1.61B 70.22B 1.83B 487M 439M 406M 367M 694M 45.72B 711M 4.86B 1.94B 24.48B 1.79B 77.92B
Net income 491M 131M 118M 109M 98.42M 186M 12.26B 191M 1.3B 520M 6.57B 480M 20.9B 540M 144M 130M 120M 108M 205M 13.5B 210M 1.44B 573M 7.23B 529M 23.01B
Net Debt -326M -86.86M -78.29M -72.33M -65.39M -124M -8.15B -127M -867M -346M -4.36B -319M -13.89B -364M -96.99M -87.42M -80.76M -73.01M -138M -9.1B -142M -968M -386M -4.87B -356M -15.5B
Projected Income Statement - Annual - Jamjoom Pharmaceuticals Factory Company
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company is a Saudi Arabia-based entity which is primarily engaged in manufacturing, production, marketing, and distribution of pharmaceutical products. The Company is organized into two segments which are pharmaceutical products, consumer health products. Pharmaceutical products represent medicines or drugs, and they are essential for the prevention and treatment of diseases, and protection of public health; Consumer health products represent products used to support personal well-being, maintain health, or address specific health-related needs. The activities of the Company include producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates approximately 7 branches in Saudi Arabia.
Employees
-
Date Price Change Volume
12/11/26 SAR 115.60 -0.34% 5,301
11/11/26 SAR 116.00 +2.38% 94,548
10/11/26 SAR 113.30 +0.44% 95,505
09/11/26 SAR 112.80 -0.88% 47,236
08/11/26 SAR 113.80 -0.35% 10,781
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Jamjoom Pharmaceuticals Factory Company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
116.00SAR
Average target price
152.16SAR
Spread / Average Target
+31.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Jamjoom Pharmaceuticals Factory Company
  1. Stock Market
  2. Stocks
  3. 4015 Stock